Sławomir Karoń

Sławomir Karoń

Auto-generated profile, based on publicly available information

Sławomir Karoń

Wojewódzki Szpital Specjalistyczny nr 5 im. św. Barbary

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
DPDaria Pedrycz
Daria Pedrycz
MDMateusz Drabczyk
Mateusz Drabczyk
EPEmilia Pedrycz
Emilia Pedrycz
KKKarolina Karoń
Karolina Karoń
GDGrzegorz Drapała
Grzegorz Drapała
SKSławomir Karoń
Sławomir Karoń
Citrulline, a non-essential amino acid and precursor to L-arginine, plays a pivotal role in nitric oxide (NO) synthesis, with profound implications for vascular health and neuroprotection. By enhancing NO production, citrulline supports endothelial function, vasodilation, and cerebral circulation, thereby mitigating cognitive decline associated with aging and neurodegenerative diseases. Unlike direct arginine supplementation, citrulline offers superior bioavailability, bypassing first-pass metabolism and achieving sustained plasma levels of arginine. Furthermore, citrulline's antioxidant properties counteract oxidative stress by modulating reactive oxygen species (ROS), reducing lipid peroxidation, and protecting neuronal integrity. Emerging evidence suggests its potential in delaying endothelial senescence and preventing ferroptosis, establishing its role in vascular and neuroprotective strategies. Dietary sources, such as watermelon juice, further enhance citrulline’s accessibility, combining its bioactivity with additional antioxidants like lycopene. While existing studies underscore its promise, targeted research is needed to confirm its direct impact on cognitive function and explore its application in neurodegenerative populations. This review synthesizes current knowledge on citrulline's mechanisms, therapeutic potential, and broader implications for aging and vascular health.

6 April 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
AZAnna Ewa Zygmunt
Anna Ewa Zygmunt
MDMateusz Drabczyk
Mateusz Drabczyk
KKKarolina Karoń
Karolina Karoń
ŁKŁukasz Mikołaj Karoń
Łukasz Mikołaj Karoń
WGWojciech Krzysztof Grabowski
Wojciech Krzysztof Grabowski
SKSławomir Karoń
Sławomir Karoń
The gut microbiota, a complex ecosystem of microorganisms within the gastrointestinal tract, has emerged as a critical regulator of metabolic health. This review explores the intricate relationship between gut microbiota and insulin resistance, focusing on the underlying mechanisms, compositional changes, and therapeutic implications. Dysbiosis, characterized by reduced microbial diversity and an imbalance between beneficial and pathogenic species, contributes to insulin resistance through impaired short-chain fatty acid (SCFA) production, gut barrier dysfunction, and systemic inflammation. Key bacterial taxa, such as Akkermansia muciniphila and Faecalibacterium prausnitzii, play pivotal roles in maintaining metabolic homeostasis, while alterations in the Firmicutes-to-Bacteroidetes ratio and increased endotoxin production exacerbate metabolic dysfunction. Evidence suggests that modifiable factors, including diet, physical activity, and microbiota-targeted therapies like probiotics, prebiotics, and fecal microbiota transplantation (FMT), offer potential avenues for restoring microbial balance and mitigating insulin resistance. Despite advancements, research in this field faces challenges, including methodological variability, interindividual microbiota differences, and a need for standardized clinical approaches. Future studies should focus on long-term, large-scale interventional trials, personalized microbiota-based interventions, and elucidation of the gut microbiota's molecular mechanisms. This review underscores the promising role of gut microbiota in managing insulin resistance and highlights opportunities for integrating microbiota-targeted strategies into clinical practice.

2 March 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
MDMateusz Drabczyk
Mateusz Drabczyk
KKKarolina Karoń
Karolina Karoń
AZAnna Zygmunt
Anna Zygmunt
ŁKŁukasz Karoń
Łukasz Karoń
EPEmilia Pedrycz
Emilia Pedrycz
SKSławomir Karoń
Sławomir Karoń
Tryptophan, an essential amino acid, plays a pivotal role in regulating sleep, mental health, athletic recovery and age-specific health conditions. Sleep, a fundamental biological process critical for physical and mental well-being, is intricately linked to the availability and metabolism of tryptophan. This amino acid serves as a precursor for serotonin, a neurotransmitter involved in mood regulation and melatonin, a hormone governing the sleep-wake cycle. Tryptophan’s conversion to serotonin and subsequent synthesis of melatonin underscore its influence on circadian rhythm stabilization and sleep quality enhancement. Emerging evidence supports the therapeutic potential of tryptophan supplementation in managing insomnia, optimizing recovery in athletes, and alleviating symptoms of irritable bowel syndrome (IBS). Its role in athletic recovery is particularly significant, as improved sleep quality accelerates tissue repair and enhances overall performance. Moreover, tryptophan demonstrates age-specific benefits, addressing sleep disturbances prevalent in older adults and contributing to improved mental health outcomes across various life stages. The modulation of serotoninergic pathways by tryptophan also underscores its broader implications for mood regulation and neuropsychiatric disorders.